Sharon Alroy‐Preis

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas, Frederick J. Angulo, John M. McLaughlin et al. · The Lancet · 2021 · 1.8K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Yinon M. Bar‐On, Yair Goldberg, Micha Mandel et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2

Yair Goldberg, Micha Mandel, Yinon M. Bar‐On et al. · New England Journal of Medicine · 2022 · 467 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel

Yaniv Lustig, Neta S. Zuckerman, Ital Nemet et al. · Eurosurveillance · 2021 · 159 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study

Eric J. Haas, John M. McLaughlin, Farid Khan et al. · The Lancet Infectious Diseases · 2021 · 135 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +16